MSR43 Identifying Eligibility for Chimeric Antigen Receptor T-Cell Therapy Among Diffuse Large B-Cell Lymphoma Patients Using Real-World Data and Unsupervised Machine Learning
Abstract
Authors
Y Wang M.S. Nickolich C Hsuan CS Hollenbeak D Vanness